Scinova - Company finances
|
EUR
|
2022
From: 2022-06-06
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 0 | - | 71,122 | 79,827 |
| Profit before tax | - | -4,631 | 1,127 | -454 |
| Net profit | 0 | -4,631 | 1,127 | -454 |
| Equity | 6,000 | 1,369 | 2,496 | 2,041 |
| Liabilities | 0 | 7 | 19,141 | 661 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 6,000 | 1,376 | 21,488 | 2,523 |
| Total assets | 6,000 | 1,376 | 21,488 | 2,523 |
|
Taxes paid
|
||||
| STI taxes | - | - | 1,497 | 3,683 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | - | +12.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -336.6% | 5.2% | -18.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -338.3% | 45.2% | -22.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | 1.6% | -0.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 1.6% | -0.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.0 | 7.7 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 71,122 | 79,827 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Scinova - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 2.57 |
| 2026-08-26 | 2026-09-02 | 2.57 |
| 2026-08-23 | 2026-08-23 | 2.57 |
| 2026-08-19 | 2026-08-19 | 2.57 |
| 2026-07-16 | 2026-07-17 | 117.22 |
| 2026-03-27 | 2026-03-27 | 119.70 |
| 2026-03-17 | 2026-03-19 | 119.70 |
| 2025-12-16 | 2025-12-21 | 118.43 |
| 2025-07-16 | 2025-07-30 | 105.44 |
| 2024-12-22 | 2024-12-22 | 1.11 |
| 2024-12-17 | 2024-12-20 | 1.11 |
| 2024-08-19 | 2024-08-22 | 105.90 |
| 2024-06-19 | 2024-06-20 | 106.00 |
| 2024-04-23 | 2024-04-29 | 106.70 |
| 2024-04-16 | 2024-04-22 | 106.35 |
| 2024-02-19 | 2024-02-25 | 106.35 |
Scinova - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-01-30 | 2025-01-31 | 1107.24 |
| 2024-11-01 | 2024-11-23 | 0.36 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Scinova, UAB (code 306075888) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €79.8K, up 12.2% year on year from €71.1K in 2024. Profitability weakened, however: net profit was -€454 in 2025 after a profit of €1.1K in 2024, following a loss of €4.6K in 2023. The 2025 profit margin was -0.6%, indicating that the business operated close to break-even. Over the past three years, the trend shows a move from a loss in 2023 to a small profit in 2024 and back to a modest loss in 2025, while revenue continued to rise. The balance sheet was compact in 2025, with total assets of €2.5K, equity of €2.0K and liabilities of €661. Equity represented 80.9% of assets, and debt remained low relative to equity at 0.32. Productivity remained strong, with revenue per employee at €79.8K in 2025, while the company’s profitability per employee was negative due to the small net loss.